{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:37:25Z","timestamp":1790750245569,"version":"4.1.0"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>We have previously demonstrated that oral delivery of a disease-promoting particulated antigen of<jats:italic>Leishmania amazonensis<\/jats:italic>(LaAg) partially protects mice against cutaneous leishmaniasis. In the present work, we sought to optimize a mucosal vaccine by using the intranasal route for delivery of different antigen preparations, including (i) LaAg, (ii) soluble recombinant p36\/LACK leishmanial antigen (LACK), and (iii) plasmid DNA encoding LACK (LACK DNA). BALB\/c mice that received two intranasal doses of 10 \u03bcg of LaAg and were challenged 1 week postvaccination with<jats:italic>L. amazonensis<\/jats:italic>developed delayed but effective control of lesion growth. A diminished parasite burden was accompanied by enhancement of both gamma interferon (IFN-\u03b3) and interleukin-10 levels in the lesion-draining lymph nodes. The vaccine efficacy improved with time. At 4 months postvaccination, when a strong parasite-specific TH1-type response was present in vivo, the infection was controlled for at least 5 months after challenge. In contrast to the particulated LaAg, soluble LACK (10 \u03bcg\/dose) had no effect. Interestingly, LACK DNA (30 \u03bcg\/dose), but not empty DNA, promoted rapid and durable protective immunity. Parasite growth was effectively controlled, and at 5 months after challenge LACK-reactive cells in both the mucosal and lesion-draining lymph nodes produced high levels of IFN-\u03b3. These results demonstrate for the first time the feasibility of using the intranasal route for long-lived memory vaccination against cutaneous leishmaniasis with adjuvant-free crude antigens or DNA.<\/jats:p>","DOI":"10.1128\/iai.72.8.4521-4527.2004","type":"journal-article","created":{"date-parts":[[2004,7,22]],"date-time":"2004-07-22T22:05:05Z","timestamp":1090533905000},"page":"4521-4527","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":53,"title":["Intranasal Vaccination against Cutaneous Leishmaniasis with a Particulated Leishmanial Antigen or DNA Encoding LACK"],"prefix":"10.1128","volume":"72","author":[{"given":"Eduardo Fonseca","family":"Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Olmo","family":"Pinheiro","sequence":"additional","affiliation":[{"name":"Instituto de Biofi\u0301sica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Rayol","sequence":"additional","affiliation":[{"name":"Instituto de Biofi\u0301sica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Larraga","sequence":"additional","affiliation":[{"name":"Centro de Investigaciones Biologicas, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartira","family":"Rossi-Bergmann","sequence":"additional","affiliation":[{"name":"Instituto de Biofi\u0301sica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.8.5010-5015.2001"},{"key":"e_1_3_2_3_2","first-page":"87","volume":"2","year":"2000","unstructured":"Barnes, A. G. C., C. Barnfield, R. Brew, and L. S. Klavinskis. 2000. Recent developments in mucosal delivery of pDNA vaccines. Curr. Opin. Mol. Ther.2:87-93.","journal-title":"Curr. Opin. Mol. Ther."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.3.6.875"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.11.6270-6278.2003"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.1.238-246.2004"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2003.09.008"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1999.tb01339.x"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.55.3.645-651.1987"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00769-7"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00155-X"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1432-1327.1999.00122.x","volume":"259","year":"1999","unstructured":"Gonzalez-Aseguinolaza, G., S. Taladriz, A. Marquet, and V. Larraga. 1999. Molecular cloning, cell localization and binding affinity to DNA replication proteins of the p36\/LACK protective antigen from Leishmania infantum.Eur. J. Biochem.259:909-916.","journal-title":"Eur. J. Biochem."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.7.1137"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.4049\/jimmunol.152.7.3282","volume":"152","year":"1994","unstructured":"Hamann, A., D. P. Andrew, D. Jablonskiwestrich, B. Holzmann, and E. C. Butcher. 1994. Role of alpha (4)-integrins in lymphocyte homing to mucosal tissues in-vivo. J. Immunol.152:3282-3293.","journal-title":"J. Immunol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.14.2.229-243.2001"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.4.2151-2158.2002"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5286.421"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.10.5637"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1006\/smim.1999.0177"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.163.8.4481","volume":"163","year":"1999","unstructured":"Kenney, R. T., D. L. Sacks, J. P. Sypek, L. Vilela, A. A. Gam, and K. Evans-Davis. 1999. Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis. J. Immunol.163:4481-4488.","journal-title":"J. Immunol."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80342-8"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.4049\/jimmunol.135.3.2095","volume":"135","year":"1985","unstructured":"Liew, F. Y., C. Hale, and J. G. Howard. 1985. Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection. J. Immunol.135:2095-2101.","journal-title":"J. Immunol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/314896"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02256556"},{"key":"e_1_3_2_25_2","first-page":"205","volume":"93","year":"1998","unstructured":"Marzochi, K. B. F., M. C. A. Marzochi, A. F. Silva, N. Grativol, R. Duarte, E. M. Conort, and F. Modabber. 1998. Phase 1 study of an inactivated vaccine against American tegumentary leishmaniasis in normal volunteers in Brazil. Mem. Inst. Oswaldo Cruz93:205-212.","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.4049\/jimmunol.161.9.4463","volume":"161","year":"1998","unstructured":"McCluskie, M. J., and H. L. Davis. 1998. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J. Immunol.161:4463-4466.","journal-title":"J. Immunol."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<424::AID-IMMU424>3.0.CO;2-U"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.8.4719-4725.2001"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00376-6"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(96)80606-2"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00188-8"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1538\/expanim.51.335"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00427-4"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.12.7453-7460.2001"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00032-X"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.13.040195.001055"},{"key":"e_1_3_2_37_2","first-page":"74","volume":"94","year":"1999","unstructured":"Rossi-Bergmann B., A. Lenglet, C. R. Bezerra-Santos, D. Costa-Pinto, and Y. M. Traub-Czeko. 1999. Use of fluorescent Leishmania for faster quantitation of parasite growth in vitro and in vivo.Mem. Inst. Oswaldo Cruz94(Suppl. II):74.","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030645"},{"key":"e_1_3_2_39_2","unstructured":"World Health Organization\/TDR. 1999. Tropical diseases research\u2014leishmaniasis. Fourteen Programme Report 22. World Health Organization Geneva Switzerland."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)90079-5"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.72.8.4521-4527.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.72.8.4521-4527.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T18:57:03Z","timestamp":1705172223000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.72.8.4521-4527.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1128\/IAI.72.8.4521-4527.2004"],"URL":"https:\/\/doi.org\/10.1128\/iai.72.8.4521-4527.2004","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"2004-03-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-05-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}